期刊档案 · Medicine-Medicine (miscellaneous)

Biomedical Technology

ISSN 2949-723X · KeAi Communications Co., Ltd. · China

Biomedical Technology 影响因子 16.4(官网公布),完全开放获取,APC 约 840 美元,投稿社区反馈审稿约 10 周,2025 年发文 30 篇,ESCI、Scopus 收录。

影响因子16.4期刊官网公布的最新值
中科院分区—未被分区表收录
审稿周期约 10 周投稿社区平均反馈
版面费840 USD完全开放获取
录用比例—暂无反馈
年发文量30 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Biomedical Technology 由 KeAi Communications Co., Ltd. 出版。按 OpenAlex 近年发文统计,该刊主要发表 Diverse Scientific and Economic Studies、Human auditory perception and evaluation、Educational Robotics and Engineering 等主题的论文,这 3 个主题约占 25.4%,主导子领域为 Biomedical Engineering。(根据 OpenAlex 主题统计与中科院分区数据生成)

Biomedical Technology is a peer-reviewed journal that drives innovation in the field of Biomedical Science and Engineering. It publishes original...

摘自期刊官网 Aims & Scope

研究方向(LetPub):Medicine-Medicine (miscellaneous)

主编 Wenguo Cui出版商官网

编委会国家分布:中国大陆 9 位(约 21%);主要国家 美国 16、中国 9、韩国 5、葡萄牙 2、中国澳门 1(共 42 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.9%
  2. Human auditory perception and evaluationEngineering8.3%
  3. Educational Robotics and EngineeringComputer Science8.3%
  4. Bone Tissue Engineering MaterialsEngineering7.7%
  5. Wound Healing and TreatmentsMedicine6.5%
  6. 3D Printing in Biomedical ResearchEngineering5.9%
  7. Electrospun Nanofibers in Biomedical ApplicationsMaterials Science5.3%
  8. Nanoparticle-Based Drug DeliveryMaterials Science4.7%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

PubMed出版商官网

其他:Crossref

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
16.4出版商官网 ·
CiteScore 2026-06
17.6LetPub ·
CiteScore(出版商公布)
17.6出版商官网 ·
SJR 2026-06
2.48LetPub ·
SNIP 2026-06
2.1LetPub ·
h-index
26OpenAlex ·
i10-index
51OpenAlex ·
两年平均被引
7.61OpenAlex ·
自引率
1.2%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
27LetPub ·

逐年发文量 OpenAlex 统计 · 累计 130 篇 · 当年数据不完整

年份发文量其中 OA被引
2026252526
20253030234
20242424341
202336361,887
20221515628

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
10 WeeksLetPub ·
投稿到发表(期刊自报)
约 10 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 840有CC BY、CC BY-NC-ND
OpenAlexUSD 0——
LetPubUSD 840有—
出版商官网USD 840——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点2 项,摘自作者指南
参考文献格式
顺序编码制(按引用顺序编号)
Highlights(研究亮点)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型19 种,含篇幅限制
  1. book reviewBook review A critical discussion of a book's contents.未说明篇幅
  2. calendarCalendar: List of forthcoming meetings, symposia, conferences, and other events.未说明篇幅
  3. commentaryFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …正文 ≤ 1,500 词 · 参考文献 ≤ 10
  4. editorialFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  5. full-length/ research articleFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required.未说明篇幅
  6. hypothesisFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  7. letterFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  8. letter to the editorFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  9. meeting reports, news and announcementsMeeting Reports, News and Announcements Meeting reports Summary of a relevant symposium, workshop, etc.未说明篇幅
  10. mini reviewFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  11. opinionFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  12. original researchFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  13. perspectiveFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …正文 ≤ 3,000 词 · 图表 ≤ 4 · 参考文献 ≤ 30
  14. protocolProtocol: an article describing the study design, with a detailed account of the hypothesis rationale, timeline, proposed methodology for data collection and an…未说明篇幅
  15. research articleFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  16. reviewFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  17. review articleFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  18. short communicationFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
  19. viewpointFull-length/ Research Article A complete report on original research and/or clinical studies. A structured abstract is required. A clear structure is required, …未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、预印本
AI 使用 Declaration of generative AI in scientific writing

作者被鼓励在投稿时声明在科学写作中使用生成式人工智能;该指南仅针对写作过程,不涉及用人工智能工具分析数据和从中获取见解的研究过程;生成式人工智能和人工智能辅助技术应仅用于提高稿件的可读性和语言水平,且必须在人类监督和控制下应用,作者应仔细审查和编辑其结果,因为人工智能可能生成听起来权威的输出。 模型中文摘要

Authors are encouraged to declare the use of generative AI in scientific writing upon submission of the paper. The following guidance refers only to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process: Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language o…

原文 ↗出版商官网 ·
作者资格 Authorship Statement

为提高透明度,鼓励作者提交作者声明文件,使用相关CRediT角色概述各自对论文的贡献(如概念化、数据管理、形式分析、经费获取、调查研究、方法学、项目管理、资源、软件、监督、验证、可视化、初稿撰写、审阅与编辑等);作者声明应将作者姓名置于前、CRediT角色随后。 模型中文摘要

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & edi…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

所有作者必须披露可能不当影响或偏袒其工作的与他人或组织的财务和个人关系;潜在竞争利益的例子包括雇佣、咨询、持股、酬金、有偿专家作证、专利申请或注册、经费资助以及作为期刊编辑或顾问委员会成员的隶属关系;应始终完成声明工具,有期刊隶属关系需声明的作者应在声明工具的“Other Activities”下输入指定文本。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board…

原文 ↗出版商官网 ·
出版伦理

向KeAi期刊的投稿会在编辑系统内自动使用iThenticate的CrossCheck进行查重筛查,以检测包括重叠和相似文本在内的抄袭问题;相似度过高的论文将被直接拒稿。 模型中文摘要

Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts. Details can be found here. High similarity papers will be desk rejected.

原文 ↗出版商官网 ·
许可与版权 Copyright

该期刊是由KeAi Communications Co., Ltd.拥有的同行评审、完全开放获取期刊,该公司保留整本期刊及各期汇编的版权;就单篇文章而言,作者保留版权及学术使用权,KeAi Communications Co., Ltd.被授予非独占的出版和发行权。 模型中文摘要

This journal is a peer-reviewed, fully open access journal owned by KeAi Communications Co., Ltd., who retains copyright of the overall compiled journal and the compiled issues. For the single article, Authors will retain copyright alongside scholarly usage rights, and KeAi Communications Co., Ltd. will be granted non-exclusive publishing and distribution rights

原文 ↗出版商官网 ·
开放获取 Open Access

该期刊发表的每篇同行评审研究论文都将开放获取,即出版后立即通过互联网永久、免费、以易读格式供所有人访问;为提供开放获取,期刊设有需由作者或其资助者、机构等代为支付的文章出版费(APC),本刊APC为840美元另加增值税;对于2026年4月1日之后提交的所有论文,另有规定(原文在此截断)。 模型中文摘要

Open access Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. To provide open access, this journal has an open access fee (also known as an article publishing charge APC) which needs to be paid by th…

原文 ↗出版商官网 ·
同行评审 Peer Review

该期刊实行单盲评审;所有投稿先由编辑评估是否适合本刊,被认为合适的论文通常送至少两名独立专家审稿人评估其科学质量;编辑对接受或拒绝文章拥有最终决定权且该决定为最终决定;编辑不参与涉及本人、家人、同事或与其有利益冲突的产品或服务的论文的决定。 模型中文摘要

This journal operates a single blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's dec…

原文 ↗出版商官网 ·
预印本 Preprint

预印本可按照Elsevier的共享政策随时随地共享,例如在预印本服务器上共享预印本不会被视为先前发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
KeAi Communications Co., Ltd.
出版国家或地区
China
出版语言
English
ISSN
2949-723X
官方链接

常见问题

关于 Biomedical Technology 的常见问题

Biomedical Technology 的影响因子是多少?

期刊官网公布的影响因子为 16.4,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 17.6,h-index 为 26。

Biomedical Technology 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 10 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Biomedical Technology 的投稿格式要求是什么?

据期刊作者指南:参考文献格式:顺序编码制(按引用顺序编号);Highlights:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Biomedical Technology 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 42 位编委中,中国大陆 9 位(约 21%);人数最多的国家是 美国(16 位)、中国(9 位)、韩国(5 位)。统计按编委会页面列出的机构国家计,仅供参考。

Biomedical Technology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Biomedical Technology 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 PubMed 收录,该清单未与各数据库逐一核对。

Biomedical Technology 是开放获取期刊吗?版面费多少?

Biomedical Technology 为完全开放获取。APC 约 840 美元。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。